Fast, Quality, Professional, Relationship

TWGHs 155th Anniversary Charity Gala

"The Incident of Wang Fuk Court, Tai Po"

To support those affected by the unfortunate accident at Wang Fuk Court in Tai Po, our company has donated HK$100,000 to Tung Wah Group of Hospitals,

hoping to help those in need within Wang Fuk Court.

Tung Wah Group of Hospitals 155th Anniversary

link: Click here

Chinese Medicine Council announces that transitional registration of proprietary Chinese medicines will end on June 30

The following is issued on behalf of the Chinese Medicine Council of Hong Kong (CMCHK):

The CMCHK announced today (June 24) that the evaluation and approval process for converting the transitional registrations of proprietary Chinese medicines (pCm) to formal registrations has been completed. The transitional registration system for pCm will come to an end on June 30. By then, all pCms sold in Hong Kong must have valid formal registrations, marking a new chapter in the regulatory regime of Chinese medicine in Hong Kong.

According to the Chinese Medicine Ordinance (Cap. 549), all pCms must be registered with the Chinese Medicines Board (CMB) under the CMCHK before they can be sold, imported or possessed in Hong Kong. The registration of pCm must comply with the stringent requirements of the CMB in respect of safety, quality and efficacy. Taking into account the actual situation of the trade, the Government implemented a transitional measure in the past. PCms manufactured or sold in Hong Kong as of March 1, 1999, and meeting the eligibility criteria for transitional registration, were allowed to continue to be sold during the application period for "Certificate of registration of pCm" (HKC) with a "Notice of confirmation of transitional registration of pCm" (HKP).

During the implementation of the transitional registration arrangement, the CMB processed a total of 14 172 cases of HKP applications and approved 9 150 for issuance of HKP. Among these cases, 6 174 cases were successfully issued with HKC, while the remaining 2 976 cases were not issued with HKCs due to reasons such as the applicants' failure to submit the required information, withdrawal of applications by the applicants, or revocation of the HKPs, among others.

In view of the time taken by the trade to adapt to the registration requirements and the impact of the pandemic, the CMB extended the deadline for submission of registration information on a number of occasions. In February 2024, the CMB made a final decision that all applications for HKC from HKP must be completed by June 30, 2025. After that, HKP will be revoked for overdue cases, and the products concerned will not be allowed to be sold, imported, or possessed in Hong Kong.

Information source from: The Government of the HKSAR

link: Click here

Sponsor and support the second Chinese Medicine Dinner organized by "The Hong Kong Society of Chinese Medicines"

"Alagate CM Fund" sponsored and supported the second Chinese medicine special dinner organized by The Hong Kong Society of Chinese Medicines -"粵港澳大灣區的最新藥品政策和實例", which raised everyone's awareness of the simple registration of proprietary Chinese medicines in the Greater Bay Area and opportunities to deepen understanding and promote the development of the industry.

The Chinese Medicine Unit of the Health Bureau visited to discuss the " Chinese Medicine Development Blueprint"

The Chinese Medicine Unit of the Health Bureau, The Hong Kong Special Administrative Region Government, is committed to formulating the " Chinese Medicine Development Blueprint " and appointed Dr Vincent Chung Chi-ho as the Commissioner for Chinese Medicine Development on May 20 of 2024, responsible for jointly formulating the "Blueprint" with the Chinese medicine industry.

Our company is honored to have a dedicated representative from the "Chinese Medicine Unit" visit to discuss and put forward important opinions, issues, developments, and prospects of the Chinese medicine industry to the Bureau, to assist in formulating the "Blueprint".